We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+0.18%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$325B
AUM Growth
-$10.8B
Cap. Flow
-$13.7B
Cap. Flow %
-4.23%
Top 10 Hldgs %
22.35%
Holding
3,492
New
145
Increased
887
Reduced
2,282
Closed
80

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.03B
2
AAPL icon
Apple
AAPL
+$962M
3
INTC icon
Intel
INTC
+$470M
4
MSFT icon
Microsoft
MSFT
+$449M
5
HD icon
Home Depot
HD
+$432M

Sector Composition

Rank Sector Weight
1 Technology 25.61%
2 Financials 13.19%
3 Healthcare 12.42%
4 Consumer Discretionary 12.29%
5 Communication Services 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NL icon
3251
NLI Holdings
NL
$343M
$214K ﹤0.01%
34,748
-1,155
-3% -$7.25K
RPID icon
3252
Rapid Micro Biosystems
RPID
$55.7M
$200K ﹤0.01%
+10,806
New +$223K
MIRM icon
3253
Mirum Pharmaceuticals
MIRM
$5.82B
$199K ﹤0.01%
11,020
– –
CYT
3254
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$193K ﹤0.01%
+10,992
New +$205K
ABOS icon
3255
Acumen Pharmaceuticals
ABOS
$162M
$192K ﹤0.01%
+12,922
New +$215K
ALPN
3256
DELISTED
Alpine Immune Sciences Inc
ALPN
$184K ﹤0.01%
18,446
– –
YI
3257
111 Inc
YI
$31.7M
$183K ﹤0.01%
2,971
-6,457
-68% -$431K
LEGH icon
3258
Legacy Housing
LEGH
$697M
$182K ﹤0.01%
10,412
-15,690
-60% -$281K
DTP
3259
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
– –
0
– –
EPIX
3260
DELISTED
ESSA Pharma
EPIX
$181K ﹤0.01%
+22,642
New +$360K
ATER icon
3261
Aterian
ATER
$11.9M
$177K ﹤0.01%
1,332
-3,449
-72% -$382K
SRGA
3262
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$177K ﹤0.01%
5,407
– –
FNCH
3263
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$176K ﹤0.01%
400
– –
OMIC
3264
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$169K ﹤0.01%
+504
New +$258K
SPRB
3265
Spruce Biosciences
SPRB
$140M
$164K ﹤0.01%
307
-88
-22% -$55.3K
ASPU
3266
DELISTED
ASPEN GROUP, INC.
ASPU
$164K ﹤0.01%
29,461
– –
SGTX
3267
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$163K ﹤0.01%
2,057
+183
+10% +$14.1K
CMLS
3268
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$158K ﹤0.01%
12,904
– –
VERO
3269
DELISTED
Venus Concept
VERO
$157K ﹤0.01%
380
– –
LSEA
3270
DELISTED
Landsea Homes
LSEA
$153K ﹤0.01%
17,838
+4,154
+30% +$35.6K
MBII
3271
DELISTED
Marrone Bio Innovations, Inc.
MBII
$151K ﹤0.01%
172,042
-49,541
-22% -$59.6K
TERN
3272
DELISTED
Terns Pharmaceuticals
TERN
$150K ﹤0.01%
14,237
– –
XPOF icon
3273
Xponential Fitness
XPOF
$165M
$145K ﹤0.01%
+11,400
New +$132K
GHG
3274
GreenTree Hospitality
GHG
$102M
$140K ﹤0.01%
+17,128
New +$158K
LNSR icon
3275
LENSAR
LNSR
$85M
$137K ﹤0.01%
17,865
– –

Similar funds

Nuveen's Q3 2021 Portfolio in Review

As of Q3 2021, Nuveen held 3,492 positions worth $325B, down 3.2% from $335B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen withdrew a net $13.7B in Q3 2021, closing 80 positions and reducing 2,282 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $219M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Nuveen opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $596M.

  • Nuveen's largest Q3 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,810,000 shares worth $596M.
  • Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2021, an estimated $899M increase.
  • Nuveen's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $1.03B.
  • Nuveen fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $219M.
  • Nuveen's ten largest holdings make up 22% of its $325B portfolio in Q3 2021.
  • Nuveen opened 145 new positions and closed 80 in Q3 2021.
  • Nuveen's portfolio value fell 3.2% quarter-over-quarter to $325B.

Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.